0001411920-16-000003.txt : 20160513 0001411920-16-000003.hdr.sgml : 20160513 20160512201219 ACCESSION NUMBER: 0001411920-16-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160513 DATE AS OF CHANGE: 20160512 EFFECTIVENESS DATE: 20160513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IRX Therapeutics, Inc. CENTRAL INDEX KEY: 0001411920 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-263122 FILM NUMBER: 161645542 BUSINESS ADDRESS: STREET 1: 140 W 57th St STREET 2: SUITE 3D CITY: New York STATE: NY ZIP: 10019 BUSINESS PHONE: 212-582-1199 MAIL ADDRESS: STREET 1: 140 W 57th St STREET 2: SUITE 3D CITY: New York STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: IRX Therapeutics Inc DATE OF NAME CHANGE: 20070910 D 1 primary_doc.xml X0707 D LIVE 0001411920 IRX Therapeutics, Inc. 140 W 57th St SUITE 3D New York NY NEW YORK 10019 212-582-1199 DELAWARE IRX Therapeutics Inc Corporation true Jeffrey Hwang c/o IRX Therapeutics, Inc. 140 W. 57th St., Suite 3D New York NY NEW YORK 10019 Executive Officer Curtis P. Robb c/o IRX Therapeutics, Inc. 140 W. 57th St., Suite 3D New York NY NEW YORK 10019 Executive Officer Zygmund Roth c/o IRX Therapeutics, Inc. 140 W. 57th St., Suite 3D New York NY NEW YORK 10019 Executive Officer John W. Hadden II c/o IRX Therapeutics, Inc. 140 W. 57th St., Suite 3D New York NY NEW YORK 10019 Executive Officer Director David H. Deming c/o IRX Therapeutics, Inc. 140 W. 57th St., Suite 3D New York NY NEW YORK 10019 Director George P. Denny III c/o IRX Therapeutics, Inc. 140 W. 57th St., Suite 3D New York NY NEW YORK 10019 Director John D. Halpern c/o IRX Therapeutics, Inc. 140 W. 57th St., Suite 3D New York NY NEW YORK 10019 Director Ferid Murad c/o IRX Therapeutics, Inc. 140 W. 57th St., Suite 3D New York NY NEW YORK 10019 Director Lawrence M. Wolf c/o IRX Therapeutics, Inc. 140 W. 57th St., Suite 3D New York NY NEW YORK 10019 Director Charles R. Cherington c/o IRX Therapeutics, Inc. 140 W. 57th St., Suite 3D New York NY NEW YORK 10019 Director Biotechnology Decline to Disclose 06b false 2016-04-30 false true true false 0 15000000 2000000 13000000 false 1 0 0 0 true false IRX Therapeutics, Inc. Jeffrey Hwang Jeffrey Hwang President 2016-05-12